EpiPen Competitor Auvi-Q Relauching With Ultimate Copay: $0
Executive Summary
Under kaléo's new access program, patients with insurance will have no co-pay and uninsured people with less than $100,000 income will get the product for free.
You may also be interested in...
Tymlos Inclusion Stands Out As Express Scripts Reveals 2018 Formulary
Radius Health's pricing and reimbursement strategy has been successful, at least with Express Scripts, which included its bone-builder Tymlos on a 2018 formulary that excludes several brand-name drugs.
EpiPen Price Story Highlights Growing Impact Of Drug Deductibles
Nearly half of employer-sponsored insurance plans surveyed require members to meet a deductible before coverage for a prescription drug is approved.
EpiPen Outrage In Congress Puts Spotlight On FDA Generic Review
House and Senate letters ask why Mylan's autoinjector doesn't have competition, offering a preview of potential debates on renewal of the generic user fee program.